AusBiotech 2024 and AusBioInvest 2024, Australia’s premier life science and life science investment conferences, have opened early bird registrations.
The countdown is on for Australia’s biggest week in biotech’ being held from 29 October-1 November in Melbourne, with early-bird registrations now open for the week’s flagship events.
AusBiotech 2024 will connect more than 1,200 delegates to ‘unite through innovation’ and highlight the latest advancements, trends, and opportunities currently facing the life sciences sector locally and globally.
Held from 30 October-1 November at the Melbourne Convention & Exhibition Centre, AusBiotech 2024 will feature an industry-led, gender diverse programme with more than 170 speakers across 50+ sessions developed to inform, educate, celebrate, and inspire the life science community.
The AusBiotech national conference has served as the leading international meeting place for the Australian life science community for over 38 years. This year’s conference will include:
- Three days of programme sessions, featuring an impressive lineup of 120+ expert speakers;
- Our industry partners – connect in the exhibition hall;
- AusPartnering, AusBiotech’s highly popular business matching programme, facilitating thousands of 1:1 meetings across the conference week;
- Networking opportunities with other delegates and partners;
- The AgriBiotech and BioSecurities Summit – a one-day agri-bio focused summit held onsite at AusBiotech 2024;
- The Early-Stage Innovation Forum – discover emerging technologies at our rapid-fire pitch competition for researchers and pre-seed companies;
- Lunch, morning and afternoon refreshments in the exhibition hall; and
- Social highlight of the week – the AusBiotech 2023 gala dinner.
Individuals can register for AusBiotech .
Connecting innovators with investors, the 18th annual AusBioInvest conference will be held on Tuesday 29 October at the Park Hyatt in Melbourne.
The full-day programme will feature thought-provoking keynotes and panel sessions with leading investors and business leaders on the trends, themes, and market conditions shaping life science investing, in addition to up to 25 presentations from early to late-stage biotech companies seeking investment and strategic partners.
Qualified investors are invited to register for a complimentary pass , while biotech companies interested in pitching are invited to apply to be an investee . Presenting investees and investors will also gain access to the exclusive Investor CEO dinner that provides a forum for executives and investors to further network and discuss potential partnership opportunities after the event.
Other professionals interested in attending are encouraged to purchase a conference delegate pass .
AusBiotech’s flagship conferences lift the profile of the Australian biotechnology industry, share new and ground-breaking knowledge, connect companies, and create access to greater funding sources for companies to develop world-class science into therapies, diagnostics and medical devices.
AusBiotech thanks its host state partner, the Victorian State Government, for its support of AusBiotech and AusBioInvest 2024.
